These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17635184)

  • 21. Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2).
    Chothe PP; Swaan PW
    Biochem J; 2014 Apr; 459(2):301-12. PubMed ID: 24498857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Janus kinase-dependent regulation of drug detoxifying protein expression by interleukin-22 in human hepatic cells.
    Le Vée M; Bruyère A; Jouan E; Fardel O
    Int Immunopharmacol; 2020 Jun; 83():106439. PubMed ID: 32234672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of influx transporter for the quinolone antibacterial agent levofloxacin.
    Maeda T; Takahashi K; Ohtsu N; Oguma T; Ohnishi T; Atsumi R; Tamai I
    Mol Pharm; 2007; 4(1):85-94. PubMed ID: 17274666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel putative bile acid transporter SLC10A5 is highly expressed in liver and kidney.
    Fernandes CF; Godoy JR; Döring B; Cavalcanti MC; Bergmann M; Petzinger E; Geyer J
    Biochem Biophys Res Commun; 2007 Sep; 361(1):26-32. PubMed ID: 17632081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review article: The function and regulation of proteins involved in bile salt biosynthesis and transport.
    Pellicoro A; Faber KN
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():149-60. PubMed ID: 18081658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans.
    Liao M; Zhu Q; Zhu A; Gemski C; Ma B; Guan E; Li AP; Xiao G; Xia CQ
    Xenobiotica; 2019 Jul; 49(7):852-862. PubMed ID: 30132394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of nuclear receptor downregulation on hepatic expression of cytochrome P450 and transporters in chronic hepatitis C in association with fibrosis development.
    Hanada K; Nakai K; Tanaka H; Suzuki F; Kumada H; Ohno Y; Ozawa S; Ogata H
    Drug Metab Pharmacokinet; 2012; 27(3):301-6. PubMed ID: 22166890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and functional characterization of drug-metabolizing enzymes and transporter expression in the novel spontaneously immortalized human hepatocyte line HC-04.
    Lim PL; Tan W; Latchoumycandane C; Mok WC; Khoo YM; Lee HS; Sattabongkot J; Beerheide W; Lim SG; Tan TM; Boelsterli UA
    Toxicol In Vitro; 2007 Dec; 21(8):1390-401. PubMed ID: 17590308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse NTCP-Mediated Rosuvastatin Uptake In Vitro and in Slc10a1-Deficient Mice.
    Russell LE; DeGorter MK; Ho RH; Leake BF; Schmerk CL; Mansell SE; Kim RB
    AAPS J; 2021 Jan; 23(1):17. PubMed ID: 33404849
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolomics study of the metabolic changes in hepatoblastoma cells in response to NTCP/SLC10A1 overexpression.
    Wang J; Tian R; Shan Y; Li J; Gao H; Xie C; Ma Y; Wu Y; Ji B; Gu S; Xu M
    Int J Biochem Cell Biol; 2020 Aug; 125():105773. PubMed ID: 32450267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
    Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
    Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free Cholesterol Affects the Function and Localization of Human Na
    Idowu JY; Hagenbuch B
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia.
    Chen HL; Liu YJ; Chen HL; Wu SH; Ni YH; Ho MC; Lai HS; Hsu WM; Hsu HY; Tseng HC; Jeng YM; Chang MH
    Pediatr Res; 2008 Jun; 63(6):667-73. PubMed ID: 18327154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular determinants in the transport of a bile acid-derived diagnostic agent in tumoral and nontumoral cell lines of human liver.
    Libra A; Fernetti C; Lorusso V; Visigalli M; Anelli PL; Staud F; Tiribelli C; Pascolo L
    J Pharmacol Exp Ther; 2006 Nov; 319(2):809-17. PubMed ID: 16895978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction.
    Hariparsad N; Carr BA; Evers R; Chu X
    Drug Metab Dispos; 2008 Jun; 36(6):1046-55. PubMed ID: 18332078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression and regulation of drug transporters in the intestine and kidney.
    Terada T; Inui K
    Biochem Pharmacol; 2007 Feb; 73(3):440-9. PubMed ID: 17137557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype.
    Fattah S; Shinde AB; Matic M; Baes M; van Schaik RHN; Allegaert K; Parmentier C; Richert L; Augustijns P; Annaert P
    Pharm Res; 2017 Jun; 34(6):1309-1319. PubMed ID: 28364304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection.
    Jung N; Lehmann C; Rubbert A; Knispel M; Hartmann P; van Lunzen J; Stellbrink HJ; Faetkenheuer G; Taubert D
    Drug Metab Dispos; 2008 Aug; 36(8):1616-23. PubMed ID: 18490433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories.
    Hayeshi R; Hilgendorf C; Artursson P; Augustijns P; Brodin B; Dehertogh P; Fisher K; Fossati L; Hovenkamp E; Korjamo T; Masungi C; Maubon N; Mols R; Müllertz A; Mönkkönen J; O'Driscoll C; Oppers-Tiemissen HM; Ragnarsson EG; Rooseboom M; Ungell AL
    Eur J Pharm Sci; 2008 Dec; 35(5):383-96. PubMed ID: 18782614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell membrane transport of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the liver and systemic bioavailability.
    Yang MC; McLean AJ; Le Couteur DG
    Biochem Biophys Res Commun; 2001 Nov; 289(1):130-6. PubMed ID: 11708789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.